发明名称 |
Spongosine for inhibiting pain perception from neuropathic and inflammatory pain even when administered at doses expected to give concentrations well below those known to activate adenosine receptors |
摘要 |
Spongosine for inhibiting pain perception in mammals suffering from neuropathic and inflammatory pain even when administered at doses expected to give concentrations well below those known to activate adenosine receptors. Thus, spongosine is used to treat neuropathic and inflammatory pain without causing the significant side effects associated with administration of other adenosine receptor agonists.
|
申请公布号 |
NZ540353(A) |
申请公布日期 |
2006.11.30 |
申请号 |
NZ20030540353 |
申请日期 |
2003.12.09 |
申请人 |
CAMBRIDGE BIOTECHNOLOGY LIMITED |
发明人 |
RICHARDSON, PETER |
分类号 |
A61K31/197;A61K31/52;A61K31/7076;A61P25/00;(IPC1-7):A61K31/707 |
主分类号 |
A61K31/197 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|